Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells  by Besnard, Valerie et al.
Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2
and IGFBP-3 expression in oxidant exposed lung epithelial cells
Valerie Besnard a, Sophie Corroyer a, Germain Trugnan b, Katarina Chadelat a,
Elodie Nabeyrat a, Ve¤ronique Cazals a, Annick Clement a;*
a De¤partement de Pneumologie Pe¤diatrique, INSERM U515, Ho“pital Trousseau AP-HP, Universite¤ Paris VI, 26, Ave Dr. Netter,
75012 Paris, France
b CJF-INSERM U96-07, Ho“pital St. Antoine, Universite¤ Paris VI, Paris, France
Received 1 July 1999; received in revised form 24 October 2000; accepted 5 December 2000
Abstract
Oxygen (O2) species are involved in a large variety of pulmonary diseases. Among the various cell types that compose the
lung, the epithelial cells of the alveolar structure appear to be a major target for oxidant injury. Despite their importance in
the repair processes, the mechanisms which regulate the replication of the stem cells of the alveolar epithelium, the type 2
cells, remain poorly understood. Based on the results of several studies which have documented the involvement of the
insulin-like growth factor (IGF) system in lung epithelial cell replication, and which have also suggested a role for IGF
binding proteins (IGFBPs) in the control of cell proliferation, the aim of the present work was to determine whether IGFBPs
could be involved in the modulation of growth of human lung epithelial cells exposed to oxidants. Experiments were
performed using a human lung adenocarcinoma cell line (A549) which was exposed for various durations to hyperoxia (95%
O2). We observed a rapid and reversible growth arrest of the cells after only 24 h of O2 exposure. When oxidant injury was
prolonged, growth arrest was followed by induction of apoptosis with activation of the Fas pathway. These effects were
associated with an increased expression of IGFBP-2 and IGFBP-3. In addition, study of localization of these proteins
revealed distinct patterns of distribution. IGFBP-3 was mainly present in the extracellular compartment. In comparison, the
fraction of IGFBP-2 secreted was less abundant whereas the IGFBP-2 fraction in the intracellular compartment appeared
stronger. In addition, analysis of the subcellular localization provided data indicating the presence of IGFBP-2 in the
nucleus. Taken together these data support a role for IGFBP-2 and IGFBP-3 in the processes of growth arrest and apoptosis
in lung epithelial cells upon oxidant exposure. They also suggest that distinct mechanisms may link IGFBP-2 and IGFBP-3
to the key regulators of the cell cycle. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Oxidative stress represents a major insult for the
alveolar structure of the lung. This is well explained
by the location and anatomy of the respiratory sys-
tem which o¡ers an extensive surface area available
to react with all sources of oxidants of endogenous
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as well as exogenous sources. Reactive oxygen (O2)
species have been implicated in the development of a
number of pathological processes based on their abil-
ity to interact with and modify a spectrum of bio-
molecules [1]. In most cells, a major target of oxida-
tive stress is DNA [2]. In response to oxidant-
induced DNA damage, it is now established that cells
need to coordinately arrest cell cycle progression and
induce expression of a number of genes whose prod-
ucts are essential for the resolution of the lesions [3^
5].
Experiments performed using animal models ex-
posed to various forms of oxidants have documented
the deleterious e¡ects on the cells which compose the
alveolar epithelium, the type 1 and type 2 cells [6,7].
The cells most vulnerable to many toxic agents are
the type 1 cells. These cells are terminally di¡erenti-
ated cells and are unable to proliferate. Therefore,
once damaged, their replacement relies on the ability
of type 2 cells to divide and to provide cells which
will undergo transition into type 1 cells [8]. Thus,
repair of the alveolar epithelium after injury is linked
to the control of proliferation of type 2 cells.
The mechanisms which regulate type 2 cell repli-
cation upon oxidant exposure remain poorly under-
stood. In previous studies, using a rat type 2 epithe-
lial cell line, we have reported the involvement of
several components of the insulin-like growth factor
(IGF) system in the control of proliferation. Partic-
ularly, we have found that block of type 2 cell pro-
liferation was associated with accumulation of the
IGF binding protein (IGFBP)-2 [9^11]. The IGFBPs
are a complex family of proteins which have highly
conserved N-terminal and C-terminal domains, and
which bind IGFs with high a⁄nity [12]. Despite these
similarities, the IGFBPs display various patterns of
expression depending on cell types and local environ-
ment. They also have distinctive properties, and can
interfere with various biological processes by their
ability to modulate IGF e¡ects as well as through
IGF independent mechanisms [12].
Based on (i) the important issue of regulation of
alveolar cell replication in response to oxidative
stress, (ii) the results of recent reports in the litera-
ture suggesting a role for IGFBPs in the process of
cell proliferation, and (iii) our previous studies doc-
umenting the involvement of IGFBP-2 in the growth
arrest of rat alveolar epithelial cells, one question
which needs to be addressed is whether IGFBPs
could be involved in the modulation of proliferation
of human lung epithelial cells exposed to hyperoxia
(95% O2). Therefore, the aim of the present work
was to characterize the e¡ects of oxidant exposure
on the production and cellular localization of
IGFBP-2 and IGFBP-3, the main IGFBPs produced
by human lung epithelial cells [13,14].
2. Materials and methods
2.1. Cells and cell culture conditions
Human alveolar lung adenocarcinoma A549 cells
were obtained from the American Type Culture Col-
lection (ATCC CCL 185, Rockville, MD, USA).
Cells were cultured in F-12 (Gibco BRL, Grand
Island, NY, USA) medium supplemented with 50 U
of penicillin/ml, 50 Wg of streptomycin/ml, and 10%
fetal bovine serum (FBS).
For control conditions, cells were maintained in
5% CO2-95% air atmosphere at 37‡C. For hyperoxia
treatment, cells were placed in sealed humidi¢ed
chambers £ushed with 5% CO2, 95% O2, as previ-
ously described [15]. Media were changed every 48 h.
For each protocol, at least three independent ex-
periments were performed.
2.2. Proliferation and apoptosis studies
2.2.1. Proliferation studies
Exponentially growing cells were plated at a den-
sity of 5U104 cells/cm2. Three days later, the me-
dium was changed and the cells were placed either
in control atmosphere or in hyperoxia for the indi-
cated times. Cell proliferation was evaluated by mea-
surement of cell number as previously described:
cells were harvested with trypsin-EDTA and counted
in triplicate using a hemocytometer [16].
2.2.2. DNA synthesis assay
Exponentially growing cells were plated at a den-
sity of 5U104 cells/cm2. Three days later, the me-
dium was changed and the cells were placed either
in control atmosphere or in hyperoxia for the indi-
cated times. For autoradiography of labeled nuclei,
cells were incubated for 24 h in medium containing
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2 WCi/ml [methyl-3H]thymidine (60^70 Ci/mmol), as
previously described [15]. The plates were then
washed three times with cold phosphate-bu¡ered
saline (PBS; 20 mM Tris-HCl, pH 7.6, and 137 mM
NaCl), ¢xed with methanol, air-dried, and coated
with NTB-2 liquid emulsion (Eastman Kodak, Ro-
chester, NY, USA). Twenty-four hours later, they
were developed with Kodak rapid ¢x. After being
stained with Giemsa, an average of 300 cells in ran-
dom ¢elds were examined at a magni¢cation of
U400, and the percentage of labeled nuclei was cal-
culated.
2.2.3. Apoptosis studies
2.2.3.1. Staining using 7-amino-actinomycin D,
CD95 and £ow cytometry. After treatment, cells
were washed three times with cold PBS, harvested
with trypsin-EDTA and counted using a hemocy-
tometer. Cells were then centrifuged (1000Ug for
10 min) and the pellet was resuspended in PBS to
obtain a cell concentration of 5U105^106 cells/ml.
For immunostaining with CD95, monoclonal anti-
body Fas (UB2)-FITC (Immunotech, Marseille,
France) was used. Immunostaining with 7-amino-ac-
tinomycin D (7-AAD, Sigma) was performed as pre-
viously described by Schmid et al. [17]. Cells were
incubated with 7-AAD 1 mg/ml or with CD95 10
Wg/ml or with mouse IgG1 FITC 0.5 Wg/ml (Bec-
ton-Dickinson Immunocytometry Systems, San
Jose, CA, USA) for 20 min in the dark and rinsed
two times in PBS. Cells were resuspended in 1 ml of
PBS and cell £uorescence intensities were measured
using a cytometer FACSort (Becton-Dickinson) and
analyzed by program Cell Quest version 1.2.2 (Bec-
ton-Dickinson).
2.2.3.2. Acridine orange. Dye mix (acridine or-
ange (Sigma) 100 Wg/ml PBS, and ethidium bromide
(Sigma) 100 Wg/ml PBS) was added to the cell sus-
pension at 5U105^5U106 cells/ml in complete F-12
medium and mixed gently by hand. Part of the mix-
ture was placed on a microscope slide with a cover-
slip and examined with a microscope having a ¢lter
combination suitable for observing £uorescein. A
minimum of 200 total cells was counted for each
condition and the percentage of apoptotic cells was
determined.
2.3. Protein studies
2.3.1. Preparation of conditioned medium
Cells were cultured under either control atmos-
phere or under hyperoxia. Eight hours before the
end of the experiment, the cells were washed three
times with serum-free medium, and incubated for an
additional 8 h in serum-free medium. The condi-
tioned medium was then harvested, centrifuged
(1000Ug for 10 min) to remove debris and unat-
tached cells, desalted on Sephadex G-25 columns
(Pharmacia-LKB, Sweden) and lyophilized. The pel-
let was dissolved in a volume of 2ULaemmli bu¡er
adjusted to the cell number (40 Wl for 8U105 cells).
2.3.2. Preparation of total cellular proteins
Cells (8U105) were washed three times with cold
PBS, harvested with trypsin-EDTA and counted us-
ing a hemocytometer. Cells were then centrifuged
(1000Ug for 10 min) to remove PBS and lysed by
addition of 40 Wl lysis bu¡er (250 mM NaCl, 50 mM
HEPES pH 7.0, 5 mM EDTA, 1 mM dithiothreitol
(DTT), 0.1% Nonidet NP40, 10 Wg/ml aprotinin,
10 Wg/ml leupeptin, 50 Wg/ml phenylmethylsulfonyl
£uoride, 2 mM sodium pyrophosphate, 1 mM so-
dium orthovanadate) during 30 min at 4‡C, under
agitation. After centrifugation (10 000Ug, 30 min,
4‡C), supernatant was harvested and stored frozen
at 320‡C until use.
2.3.3. Preparation of nuclear extracts
Cells (3U106) were washed three times with cold
PBS, harvested with trypsin-EDTA and counted us-
ing a hemocytometer. Cells were then centrifuged
(1000Ug for 10 min) to remove PBS, washed rapidly
in 5 vols. of lysis bu¡er (10 mM HEPES, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT, 1% NP-40, 10
Wg/ml aprotinin, 10 Wg/ml leupeptin, 1 mM phenyl-
methylsulfonyl £uoride), lysed in 3 vols. of lysis bu¡-
er during 1 h at 4‡C. After centrifugation (15 min,
4‡C, 3300Ug), supernatant was harvested and con-
stituted the cytosolic fraction. The pellet was washed
in lysis bu¡er, then resuspended gently in 1 vol. of
storage bu¡er (20 mM HEPES, 1.5 mM MgCl2,
300 mM KCl, 0.5 mM DTT, 0.2 mM EDTA, 25%
glycerol, 10 Wg/ml aprotinin, 10 Wg/ml leupeptin,
1 mM phenylmethylsulfonyl £uoride). After agitation
(4‡C, 30 min) and centrifugation (30 min, 4‡C,
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25 000Ug), supernatant representing the nuclear
fraction was collected and stored frozen at 380‡C
until use.
2.3.4. Western immunoblot analysis
Equal volumes of samples were loaded for each
experimental condition and analyzed on SDS-
PAGE (11% acrylamide). Western blots were pre-
pared by transferring the proteins onto 0.45 Wm ni-
trocellulose (NC) membranes (Bio-Rad, Richmond,
CA, USA) for 90 min at 130 V. Immunoblotting was
performed by ¢rst saturating the NC sheet for 2 h at
room temperature in PBS, containing 0.2% Tween
(PBS-T) and 10% powdered milk. This was followed
by incubation with diluted antiserum in 5% milk-PBS
for 20 h at 4‡C. The rabbit anti-bovine IGFBP-2 and
the rabbit polyclonal anti-human IGFBP-3 antise-
rum were used at 1/1000 dilution (UBI, Lake Placid,
NY, USA). The membranes were then washed three
times in PBS-T bu¡er and incubated for 1 h at 37‡C
with horseradish peroxidase-conjugated goat anti-
rabbit immunoglobulin G (Amersham, UK), diluted
1/6000 in 5% milk-PBS. The membranes were
washed three times in PBS-T, after which they were
incubated for 1 min at room temperature in chem-
iluminescence reaction detection reagents (ECL
Western blotting, Amersham). The membranes were
then exposed to autoradiography ¢lm (Hyper¢lm-
ECL, Amersham). In some experiments, the speci¢c-
ity of anti-IGFBP-2 antibody was assessed by prein-
cubating this antibody in the presence of either di-
luent solution (10 mM HCl) or increasing
concentrations of recombinant human (rh) IGFBP-
2 protein (GroPep, Australia) for 1 h at room tem-
perature.
2.3.5. Immuno£uorescence studies
Cells were plated on Labtek slide chambers
(ATGC) at a density of 3U103 cells/cm2. Three
days later, the medium was changed and the cells
were placed either under control atmosphere or
under hyperoxia for the indicated times. Cells were
washed three times with cold PBS and ¢xed in 4%
paraformaldehyde in Ca2 and Mg2 containing
phosphate-bu¡ered saline (PBS+, pH 7.4; Gibco
BRL, France) for 1 h at room temperature, followed
by a three times 5 min rinse in PBS+. After ¢xation,
slides were either placed for 15 min at room temper-
ature (RT) in blocking bu¡er (PBS+ containing BSA
1%, NH4Cl 50 mM) or in permeabilization bu¡er
(PBS3, containing saponin 0.075% and BSA 1%).
After washing, slides were incubated overnight at
4‡C in a humidi¢ed chamber with a 1/200 dilution
of antibody to IGFBP-2 or to IGFBP-3 in 50 Wl
blocking or permeabilization bu¡er. Controls in-
cluded cells incubated with 1% BSA and rabbit
IgG 0.5 Wg/ml (Vector Laboratories, USA). In
some experiments, the speci¢city of anti-IGFBP-2
antibody was assessed by preincubating this antibody
in the presence of either diluent solution (10 mM
HCl) or increasing concentrations of rh IGFBP-2
protein for 1 h at room temperature. After washing
four times with PBS containing 50 mM NH4Cl for
5 min each time, slides were incubated with £uores-
cein (FITC)-conjugated A⁄niPure donkey anti-rab-
bit IgG (Jackson ImmunoResearch Laboratories,
USA) diluted 1/200 in blocking bu¡er for 1 h at
37‡C. After washing four times with PBS containing
50 mM NH4Cl for 5 min each time, slides were in-
cubated, ¢rst for 20 min with ribonuclease A at
1 mg/ml in PBS pH7.0 at RT, second for 9 min
with propidium iodide 0.05^0.2 Wg/ml in TBS (Tris
Fig. 1. E¡ects of hyperoxia on lung epithelial cell proliferation.
(A) Proliferative cells were cultured for the indicated times
under air (control) or under hyperoxia (95% O2). At the end of
culture, cells were harvested and the cell number was measured
using a hemocytometer. (B) Proliferative cells were cultured for
the indicated times under air (control) or under hyperoxia (95%
O2) and then shifted to air for 24 or 48 h. At the end of cul-
ture, the cell number was determined. The mean and S.E.M.
for three independent experiments performed in triplicate are
shown. *P6 0.05 vs. control conditions.
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base 0.05 M, NaCl 0.15 M). Slides were rinsed three
times for 5 min in PBS3 and incubated with the
antibleaching agent 1,4-diazabicyclo[2.2.2]octane,
0.1 Wg/ml in PBS3. Samples were mounted with Vec-
tashield (Vector Laboratories, USA). Fluorescence
was observed using a Leica TCS equipped with a
DMR inverted microscope and a 63/1.4 objective.
A krypton/argon mixed gas laser was used to gener-
ate two bands: 488 nm for FITC and 568 nm that
was used for propidium iodide (PI) detection. A
‘bandpass’ ¢lter was used to recover FITC £uores-
cence and a long pass LP 590 was used for PI. Both
£uorochromes were excited and analyzed in one pass
with no interference between the two channels. Im-
age processing was performed using the on-line ‘Scan
Ware’ software. Numeric images were stored on CD
or transferred on a Power Mac 8100 equipped with
an image analysis station (Image 1.61 and Photo-
Shop 4.0) and mounted images were printed on a
Kodak XLS 8600 PS printer.
2.4. Statistical analysis
Results were reported as the mean þ S.E.M. Data
were analyzed using ANOVA, followed, when
adapted, by Mann-Whitney U test for multiple com-
parisons against control conditions. Signi¢cance was
assigned for P6 0.05.
3. Results
3.1. E¡ects of hyperoxia on cell proliferation
We ¢rst documented the e¡ects of hyperoxia on
human lung alveolar cell proliferation. Exponentially
proliferating cells were cultured under 95% O2 for
the indicated times. As shown in Fig. 1A, hyperoxia
exposure led to a rapid inhibition of cell proliferation
with no increase in cell number after 16 h of O2
exposure (P6 0.05 vs. control conditions). To deter-
mine whether this growth arrest was reversible, cells
were exposed to hyperoxia for the indicated times
and then replaced under control conditions for an
additional 24 or 48 h (Fig. 1B). After 32 h of hyper-
oxia cells could not resume proliferation when re-
placed under air as shown by the absence of rein-
crease in cell number, indicating an irreversible
growth arrest. Studies of DNA synthesis showed a
progressive reduction of the percentage of labeled
Fig. 2. Hyperoxia exposure and apoptosis in lung epithelial cells. Proliferative cells were cultured for the indicated times under air
(A), or under hyperoxia for 16 h (B), 24 h (C), or 32 h (D). At the end of culture, cells were harvested for analysis of apoptosis by
staining with 7-AAD. Apoptotic cells were stained with 7-AAD and detected by £uorescence-activated cell sorting (FACS) analysis.
For each panel, the relative log £uorescence is plotted on the abscissa (7-AAD-FL3-Height), and the cell count is plotted on the ordi-
nate. The open peaks indicate surface labeling for FITC-conjugated isotype immunoglobulin G (IgG) control, the ¢lled peaks indicate
labeling for 7-AAD.
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nuclei, and after 32 h under O2 the percentage of
labeled cells was decreased by more than 60% (data
not shown).
To determine whether apoptosis could be observed
during hyperoxia exposure, three methods were used
on adherent cells: immunostaining with 7-AAD, im-
munostaining with CD95 which evaluates the Fas
apoptotic pathway, and acridine orange staining to
selectively label apoptotic nuclei. For each set of ex-
periments, cells were exposed under air (control con-
ditions) or under hyperoxia for the indicated dura-
tions. Experiments using the 7-AAD staining method
(Fig. 2) revealed an increased percentage of cells
undergoing apoptosis during oxidant exposure, with
the following data: 5.8 þ 3.7% stained cells in control
conditions; 7.3 þ 0.6% stained cells after 16 h O2 ;
8.6 þ 0.1% stained cells after 24 h O2 ; and
43.0 þ 5.6% stained cells after 32 h O2. Immunostain-
ing with CD95 also showed a 4-fold increased label-
ing after 32 h O2 (Fig. 3). These data were con¢rmed
by acridine orange staining experiments with results
similar to the results obtained using the 7-AAD pro-
tocol. The percentages of acridine orange stained
cells were, respectively, in control conditions:
5.8 þ 0.5%; in the 16 h O2 conditions: 10.8 þ 4.5%;
and in the 32 h O2 conditions: 47.8 þ 6.7%.
3.2. E¡ects of hyperoxia on IGFBP-2 and IGFBP-3
expression
For these studies, cells were placed under hyper-
oxia for the indicated durations. Eight hours before
the end of hyperoxia, cells were washed, incubated in
serum-free medium and replaced under hyperoxia for
an additional 8 h. Conditioned media were assayed
Fig. 3. E¡ects of hyperoxia on surface expression of Fas on
lung epithelial cells. Proliferative cells were cultured for the in-
dicated times under air (P) or under hyperoxia for 16 h or 32
h. At the end of culture, cells were harvested and stained with
an anti-Fas immunoglobulin (Ig) G1 monoclonal antibody. For
each panel, the relative log £uorescence is plotted on the abscis-
sa (FITC-CD95), and the cell count is plotted on the ordinate.
The ¢lled peaks indicate surface labeling for FITC-conjugated
isotype immunoglobulin G (IgG) control, the open peaks indi-
cate FITC-conjugated anti-CD95.
Fig. 4. E¡ects of hyperoxia on IGFBP-2 and IGFBP-3 secre-
tion. Proliferative cells were cultured for the indicated times
under air (C) or under hyperoxia (O2) for 12 h, 24 h, or 32 h.
Samples of conditioned media were prepared as described in
Section 2. Proteins were fractionated on SDS-PAGE, trans-
ferred to nitrocellulose, and probed with an anti-IGFBP-2 anti-
body (A) or an anti-IGFBP-3 antibody (B). For comparison,
analysis of IGFBPs was also performed in human serum (HS).
The histograms show quantitative representations of IGFBP-2
or IGFBP-3 protein levels obtained from laser densitometric
analysis of three independent experiments. Densitometry results
were expressed as arbitrary units. *P6 0.05 vs. control condi-
tion (C).
Fig. 5. E¡ect of duration of hyperoxia exposure on IGFBP-2
expression. Proliferative cells were cultured under air (control)
or hyperoxia (O2) for 24 or 32 h. At the end of hyperoxia ex-
posure cells were prepared for protein analysis (3), or shifted
to air for an additional 24 h (+24 h air) or 48 h (+48 h air).
Samples of conditioned media were analyzed by immunoblot-
ting. Proteins were fractionated on SDS-PAGE, transferred to
nitrocellulose, and probed with an anti-IGFBP-2 antibody, as
described in Section 2. For comparison, analysis of IGFBP-2
was also performed in human serum (HS).
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for IGFBP-2 and IGFBP-3 using Western blotting
techniques. Results are shown in Fig. 4. IGFBP-2
antiserum recognized a main 34 kDa band. The in-
tensity of this band increased with the duration of O2
exposure. IGFBP-3 antiserum recognized a double
45^39 kDa band, and a signi¢cant increased expres-
sion was also observed after 24 h of hyperoxia.
To test the reversibility of hyperoxia e¡ects on
IGFBP-2 and IGFBP-3 expression, cells were ¢rst
exposed to hyperoxia for 24 or 32 h and then re-
placed under control conditions for an additional
24 or 48 h. Accumulation of IGFBPs in the condi-
tioned media was assayed as indicated above. When
cells were returned to air after a 24 h O2 exposure,
they could resume proliferation as shown in Fig. 1.
Interestingly, in this experimental condition a de-
crease in IGFBP-2 expression could be observed
(Fig. 5). By contrast, when cells were replaced under
air after a 32 h O2 exposure, no increase in cell num-
ber could be observed and this was associated with
absence of changes in the levels of IGFBP-2. Western
immunoblotting using IGFBP-3 antiserum gave sim-
ilar results (data not shown).
3.3. Extracellular and intracellular distribution of
IGFBP-2 and IGFBP-3 in oxidant-exposed cells
Based on recent reports in the literature, which
documented the presence of IGFBP-3 in the nucleus
[18^21], the cellular localization of IGFBP-2 and
IGFBP-3 in cells cultured under control conditions
and under hyperoxia was studied. Using Western
Fig. 7. Study of IGFBP-2 localization using immuno£uores-
cence analysis. Proliferative cells were cultured under control
conditions. At the end of culture, cells were ¢xed with para-
formaldehyde as described in Section 2. Fixed unpermeabilized
(a,c,e) or permeabilized (b,d,f) cells were imaged by confocal
microscopy after immunostaining with primary antibody to
IGFBP-2 and secondary antibody FITC-anti-rabbit IgG (green)
(a,b,e,f). Staining with propidium iodide (red) (c^f) visualized
the nucleus.
Fig. 6. Expression of IGFBP-2 in the cellular and extracellular
compartments. Cells were cultured for 12 h, 24 h, or 32 h
under hyperoxia (O2). Proteins from the conditioned media and
from the cellular extracts were then prepared and analyzed by
immunoblotting. (A) Secreted proteins (S) and cellular proteins
(C) were fractionated on SDS-PAGE, transferred to nitrocellu-
lose, and probed with an antibody speci¢c to an anti-IGFBP-2
antibody as described in Section 2. For comparison, analysis
was also performed in human serum (HS). (B) The histogram
shows a quantitative representation of secreted and cellular
IGFBP-2 protein levels obtained from laser densitometric analy-
sis of three independent experiments. Densitometry results were
expressed as arbitrary units. *P6 0.05 vs. 12 h secreted condi-
tion; #P6 0.05 vs. 12 h cellular condition.
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blotting experiments the distribution of IGFBP-2 in
the intracellular and extracellular compartments was
compared on the same gel. The results are presented
in Fig. 6. An increase in IGFBP-2 expression was
observed in both compartments with the durations
of hyperoxia (Fig. 6A,B). When the same blot was
analyzed for IGFBP-3 expression, the signals for
IGFBP-3 in the extracellular compartment were
more than 50 times stronger than for IGFBP-2; by
contrast the signals for IGFBP-3 in the intracellular
compartment were barely detectable (data not
shown). Taken together, these data indicate di¡eren-
ces in the localization of IGFBP-2 and IGFBP-3,
with IGFBP-3 being predominantly detected in the
extracellular compartment.
3.4. Intracellular localization of IGFBP-2
In the next set of experiments, the intracellular
localization of IGFBP-2 was analyzed by immuno-
£uorescence in cells grown on coverslips and placed
under air. Results are shown in Fig. 7. First, when
cells were not permeabilized with saponin, IGFBP-2
was detected on the plasma membrane and not with-
in the cells (Fig. 7a,e). Upon cell permeabilization,
intracellular IGFBP-2 became detectable. The nu-
cleus was strongly stained with anti-IGFBP-2 anti-
body (Fig. 7b,f). Control experiments performed ei-
ther without the ¢rst antibody or with a non-immune
rabbit serum replacing the primary antibody proved
that the above observed staining was speci¢c for
IGFBP-2 (data not shown).
To determine the speci¢city of IGFBP-2 signals,
Western immunoblotting and immuno£uorescent ex-
periments using rh IGFBP-2 protein were performed.
Increasing amounts (0 to 30 ratio) of rh IGFBP-2
were used and led to a decrease of IGFBP-2 signals
in Western blotting (Fig. 8A) as well as in immuno-
£uorescent experiments (Fig. 8B). A 30-fold excess rh
IGFBP-2 competitor successfully competed out all
IGFBP-2 signals (Fig. 8A,Bc).
The presence of IGFBP-2 in the nucleus together
with the increased intracellular expression of IGFBP-
2 in cells exposed to O2 (Fig. 6) led to the question
whether oxidant exposure could be associated with
an increased nuclear accumulation of IGFBP-2. To
provide an answer to this question, IGFBP-2 expres-
sion in the nuclear extracts of cells exposed to hyper-
Fig. 8. Speci¢city of the anti-bovine IGFBP-2 antisera. (A) Samples of conditioned media were prepared as described in Section 2.
Proteins were fractionated on SDS-PAGE, transferred to nitrocellulose, and probed with anti-IGFBP-2 antiserum that was preincu-
bated with diluent solution (C) or increasing concentrations of rh IGFBP-2. (B) At the end of culture, cells were ¢xed with paraform-
aldehyde as described in Section 2. Fixed permeabilized cells were imaged by confocal microscopy after immunostaining with primary
antibody to IGFBP-2 preincubated with diluent solution (a) or increasing concentrations of rh IGFBP-2 (b,c) and secondary antibody
FITC-anti-rabbit IgG (green). Staining with propidium iodide (red) visualized the nucleus.
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oxia for various durations was analyzed by Western
blotting. Results showed a signi¢cant increase in
IGFBP-2 protein levels in the extracts of cells ex-
posed under hyperoxia (Fig. 9).
4. Discussion
Results reported herein indicate that exposure of
human lung epithelial cells to hyperoxia led to a
rapid inhibition of cell division, and to induction of
apoptosis when oxidant injury was prolonged. This
cell response to oxidative stress was associated with
an increased expression of IGFBP-2 and IGFBP-3.
Study of localization of these proteins revealed dis-
tinct patterns of distribution. IGFBP-3 was mainly
present in the extracellular compartment. In compar-
ison, the fraction of IGFBP-2 secreted was less abun-
dant whereas the IGFBP-2 fraction in the intracellu-
lar compartment appeared stronger. In addition,
analysis of the subcellular localization provided
data indicating the presence of IGFBP-2 in the nu-
cleus.
Cell cycle arrest and induction of apoptosis have
been reported in many cell systems in situations as-
sociated with oxidant injury [6,22]. Cell cycle arrest is
thought to represent an early response to oxidative
stress. It allows the transient induction of factors
required for DNA repair, and, therefore, occurs be-
fore DNA replication in order to avoid propagation
of mutated chromosome. In the presence of high
amounts of oxidants, cell cycle arrest may not be
su⁄cient and induction of apoptosis represents a
critical event allowing elimination of cells in which
DNA damage is beyond repair [23^26]. The experi-
mental protocols used in the present work appeared
to mimic the sequence of events linked to the levels
of the oxidative stress, as a reversible block of pro-
liferation was ¢rst observed during the initial 24 h of
oxygen exposure. When the oxidative stress was pro-
longed, cells were not able to resume proliferation
when replaced in control situations and evidence of
apoptosis could be observed with involvement of the
Fas pathway. A role for apoptosis in maintaining
lung alveolar architecture has been recently pro-
posed. Fine et al. reported data showing expression
of Fas in the progenitor type 2 epithelial cells and
not in type 1 cells [27]. They postulated that Fas-
dependent apoptosis may be involved in the regula-
tion of alveolar epithelium injury and may represent
an important mechanism of repair processes. This
hypothesis is consistent with the report from Bar-
dales et al. which showed that apoptosis was a major
pathway responsible for the resolution of type 2 ep-
ithelial cells in acute lung injury [28].
A number of studies have provided evidence that
the protein p53 plays a central role in the coordi-
nated response to oxidative stress. Indeed, it has
been shown that p53 can activate the transcription
of several genes whose products are involved in cell
cycle arrest and apoptosis [6,23,26,29^31]. Among
the genes which have been shown to contain p53-
dependent cis acting DNA responsive element is the
IGFBP-3 gene. Buckbinder et al. reported an induc-
tion of IGFBP-3 in human ¢broblasts exposed to
genotoxic stress [32]. They showed that IGFBP-3 in-
duction was associated with growth inhibition on
p53. Our present data indicating increased expression
of IGFBP-3 in lung epithelial cells exposed to oxi-
dants share similarities with the study of these au-
thors. In addition to cell cycle arrest, Rajah et al.
reported that IGFBP-3 could induce apoptosis [33].
Analysis of the mechanisms involved led the authors
Fig. 9. E¡ects of hyperoxia on nuclear IGFBP-2 expression.
Cells were cultured either under air (C) or under hyperoxia
(O2) for 12 h, 24 h, or 32 h. (A) Nuclear extracts were then
prepared and proteins were analyzed by immunoblotting using
antibody speci¢c to bovine IGFBP-2, as described in Section 2.
For comparison, analysis of IGFBP-2 was also performed in
human serum (HS). (B) The histogram shows a quantitative
representation of nuclear IGFBP-2 protein levels obtained from
laser densitometric analysis of three independent experiments.
Densitometry results were expressed as arbitrary units.
*P6 0.05 vs. control condition (C).
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to suggest that the pathway of IGFBP-3-induced ap-
optosis may not necessarily involve IGF and IGF
receptor. Indeed, using IGF receptor negative ¢bro-
blasts they observed that transfection of the IGFBP-
3 cDNA resulted in a substantial increase in the de-
gree of apoptosis. In addition to mechanisms linked
to p53, it is likely that IGFBP-3 could also induce
growth arrest through a p53-independent pathway.
This is supported by the work of Rajah et al. in
PC-3 cells, which lack the p53 gene, indicating that
IGFBP-3 could initiate apoptosis through others
mechanisms such as the transforming growth factor
(TGF)-L [33]. Based on these reports, several possi-
bilities can be proposed to explain the involvement of
IGFBP-3 in the processes of growth arrest of lung
epithelial cells reported herein. These possibilities are
currently being investigated.
Our present results indicated that IGFBP-2 could
also participate in the cellular response of human
lung epithelial cells to oxidant injury. Indeed, we
showed that IGFBP-2 was induced during the se-
quential steps of reversible growth arrest and of ap-
optosis. Data reported herein are consistent with the
results of our previous studies using a rat type 2
alveolar epithelial cell line. Our interest for IGFBP-
2 in this cell line came with the results of di¡erential
screening of proteins produced by proliferative and
non-proliferative cells, which led to identify IGFBP-2
as a protein mainly expressed in growth-arrested
cells. These experiments were completed by ligand
blotting studies which revealed that IGFBP-2 was
the IGFBP predominantly produced [10]. We also
showed in various situations of growth arrest a tran-
scriptional activation of IGFBP-2 [9^11]. By contrast
when growth-arrested cells were allowed to resume
proliferation, a dramatic decrease in IGFBP-2 was
found. Recently, we reported that treatment of type
2 epithelial cells with retinoic acid, a stimulator of
cell growth, was associated with a downregulation of
IGFBP-2 expression [34]. Our present study using a
human cell line which displays some of the morpho-
logic and biochemical features of type 2 cells pro-
vides additional data supporting a role for IGFBP-
2 in the control of lung alveolar epithelial cell pro-
liferation. Involvement of IGFBP-2 in the process of
cellular growth has been reported in other cell sys-
tems. Interestingly, Park et al. showed in rat intesti-
nal epithelial cells that IGFBP-2 was the major form
of IGFBPs produced and that its expression was
associated with growth inhibition [35]. Recently, Hof-
lich et al. transfected human kidney ¢broblasts with
an IGFBP-2 expression vector and observed that
IGFBP-2 signi¢cantly reduced cell proliferation in
stably transfected cells [36].
Based on the ¢ndings that IGFBP-2 and IGFBP-3
were both induced by oxidant exposure, a possibility
emerged that the role of these proteins in the process
of growth arrest may be di¡erent. To investigate this
hypothesis we focused in the present work on the
analysis of the cellular localization of IGFBP-2 and
IGFBP-3. Data reported herein clearly showed a dis-
tinct pattern of expression of the IGFBPs. Expres-
sion of IGFBP-3 was predominantly found in the
extracellular compartment. In comparison, IGFBP-
2 was less abundant in the extracellular compartment
and its accumulation in the cellular compartment
appeared stronger. Interestingly, a new piece of in-
formation regarding IGFBP-2 was provided in the
present work with its identi¢cation in the nucleus.
Indeed, this cellular localization of IGFBP-2 has
never been reported previously. In recent years,
IGFBP nuclear localization has only been described
for IGFBP-3 and IGFBP-5. The mechanisms in-
volved in the nuclear import of IGFBPs remain un-
certain. Shedlich et al. examined the processes by
which IGFBP-3 and IGFBP-5 could translocate to
the nucleus [20]. They identi¢ed a sequence within
the basic domain of IGFBP-3 that is necessary for
its nuclear translocation, and provided data indicat-
ing a shared and saturable pathway for the nuclear
uptake of both IGFBP-3 and IGFBP-5. Regarding
IGFBP-2, the mechanisms for nuclear import are
likely to be di¡erent as the sequence in IGFBP-2
that corresponds to the putative nuclear localization
signal in IGFBP-3 does not contain the basic motif
identi¢ed in IGFBP-3 and IGFBP-5. There are two
possible ways for macromolecules to get across the
nuclear pore complex: to interact with components
of the nuclear pore complex or to di¡use from the
cytoplasmic compartment towards the nuclear com-
partment [37]. The process of di¡usion can be ob-
served for molecules of less than 50 kDa, a limit
which includes IGFBP-2. However, even for the
small proteins, di¡usion is not su⁄cient and the con-
trol of entry into the nucleus appears to require spe-
ci¢c signal-mediated mechanisms. Characterization
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of these mechanisms will represent an important step
for the understanding of the role of IGFBP-2 in the
control of lung cell proliferation, and will provide an
explanation for the increased accumulation of nu-
clear IGFBP-2 that we have documented in oxi-
dant-exposed cells.
To conclude, results obtained in the present work
provide evidence that IGFBP-2 and IGFBP-3 are
involved in the response of lung epithelial cells to
oxidant injury. They also give additional support
for a role of IGFBP-2 in the growth arrest of lung
alveolar epithelial cells. A number of questions are
now raised by these data, mainly concerning the
mechanisms by which IGFBP-2 can enter the nucleus
and can be linked to the key regulators of the cell
cycle machinery in alveolar type 2 cells. Experiments
are in progress to provide answers to these questions.
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